Drugs / 105AD7
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00007826 | Apr 2000 → ? | colorectal cancer | Onyvax | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 105AD7 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00007826 ↗ |
| Known as | MOAB 105AD7 | “monoclonal antibody 105AD7 anti-idiotype vaccine (MOAB 105AD7) plus BCG intradermally (ID) weekly for weeks 1 and 2” NCT00007826 ↗ |
| Modality | Monoclonal antibody | “monoclonal antibody 105AD7 anti-idiotype vaccine” NCT00007826 ↗ |